Pronóstico del mercado de nutrición parenteral de Asia Pacífico hasta 2030 – Análisis regional – por tipo de nutriente (solución de aminoácidos de dosis única, emulsión lipídica parenteral, carbohidratos, oligoelementos y vitaminas y minerales) y usuario final (hospitales, clínicas y otros)
Los desarrollos de nuevos productos por parte de empresas impulsan el mercado de nutrición parenteral de Asia Pacífico
Las empresas que operan en el mercado de nutrición médica parenteral se centran constantemente en nuevas lanzamientos de productos, que les ayudan a mejorar sus ventas. A continuación se mencionan algunos de los desarrollos notables en el mercado de la nutrición parenteral:
En 2023, Baxter Korea lanzó Olimel N12E, un líquido de nutrición parenteral total (NPT) rico en proteínas para pacientes críticos.
En 2023, JW Holdings comenzó a exportar Winuf Central 736/1085 ml, una nutrición parenteral total (NPT) de tres cámaras, a gran escala a Mongolia a través de AsiaPharma LLC, una empresa farmacéutica local.
Por lo tanto, se prevé que el desarrollo de nuevos productos de nutrición cree oportunidades para el crecimiento del mercado durante el período de pronóstico.
Descripción general del mercado de nutrición parenteral de Asia Pacífico
China enfrenta una alta carga de cáncer de estómago debido a la creciente prevalencia de la infección por H. pylori entre la población. Un estudio (2021) realizado por la Agencia Internacional para la Investigación del Cáncer (IARC) de la Organización Mundial de la Salud e instituciones asociadas en el Reino Unido y China encontró que la infección por H. pylori es prevalente en China. Además, la infección por H. pylori fue la causa principal del 62,1 % de los casos de cáncer gástrico del cardias y del 78,5 % de los casos de cáncer gástrico no cardias entre adultos mayores de 30 años. Este estudio de la IARC estimó que cada año se producen en China ~340.000 casos de cáncer gástrico debido a una infección por H. pylori. Según el estudio Global Burden of Diseases publicado en octubre de 2020, el cáncer de estómago estuvo entre las 10 principales causas de muerte en 2019. Del mismo modo, según los últimos datos de la Agencia Internacional para la Investigación del Cáncer (IARC), la incidencia estandarizada por edad estimada La tasa de cáncer de estómago en China es de 20,58 por 100.000 habitantes y la tasa bruta es de 33,06. Según la misma fuente, el número estimado de casos nuevos (de 0 a 74 años) en 2020 para ambos sexos fue de 478.508. Por lo tanto, debido a los factores antes mencionados, es probable que el mercado de nutrición parenteral sea testigo de un crecimiento notable en China durante el período previsto.
Ingresos del mercado de nutrición parenteral de Asia Pacífico y pronóstico hasta 2030 (millones de dólares estadounidenses)
Segmentación del mercado de nutrición parenteral de Asia Pacífico
El mercado de nutrición parenteral de Asia Pacífico está segmentado según los nutrientes tipo, usuario final y país. Según el tipo de nutriente, el mercado de nutrición parenteral de Asia Pacífico se clasifica en solución de aminoácidos de dosis única, emulsión de lípidos parenteral, carbohidratos, oligoelementos y vitaminas y minerales. El segmento de soluciones de aminoácidos de dosis única tuvo la mayor participación de mercado en 2022.
Por usuario final, el mercado de nutrición parenteral de Asia Pacífico está segmentado en hospitales, clínicas y otros. El segmento de hospitales tuvo la mayor participación de mercado en 2022.
Según el país, el mercado de nutrición parenteral de Asia Pacífico está segmentado en China, Japón, India, Australia, Corea del Sur y el resto de Asia Pacífico. China dominó la cuota de mercado de nutrición parenteral de Asia Pacífico en 2022.
ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd y Vifor Pharma Management AG son algunos de los principales actores que operan en el mercado de nutrición parenteral de Asia Pacífico.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Parenteral Nutrition Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rise in Prevalence of Gastrointestinal Diseases
4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
4.3.1 New Product Developments by Companies
4.4 Future Trends
4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis
5. Parenteral Nutrition Market - Asia Pacific Market Analysis
5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
6. Asia Pacific Parenteral Nutrition Market Analysis - by Nutrient Type
6.1 Overview
6.2 Single Dose Amino Acid Solution
6.2.1 Overview
6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
6.3.1 Overview
6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
6.4.1 Overview
6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
6.5.1 Overview
6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
6.6.1 Overview
6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Parenteral Nutrition Market Analysis - by End User
7.1 Overview
7.2 Hospitals
7.2.1 Overview
7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
7.3.1 Overview
7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Parenteral Nutrition Market - Country Analysis
8.1 Asia Pacific
8.1.1 Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
8.1.1.1 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.1 Overview
8.1.1.1.2 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.3 China: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.1.4 China: Parenteral Nutrition Market Breakdown, by End User
8.1.1.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.1 Overview
8.1.1.2.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.3 Japan: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.2.4 Japan: Parenteral Nutrition Market Breakdown, by End User
8.1.1.3 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.1 Overview
8.1.1.3.2 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.3 India: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.3.4 India: Parenteral Nutrition Market Breakdown, by End User
8.1.1.4 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.1 Overview
8.1.1.4.2 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.3 Australia: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.4.4 Australia: Parenteral Nutrition Market Breakdown, by End User
8.1.1.5 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.5.1 Overview
8.1.1.5.2 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.5.3 South Korea: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.5.4 South Korea: Parenteral Nutrition Market Breakdown, by End User
8.1.1.6 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.6.1 Overview
8.1.1.6.2 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.6.3 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.6.4 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by End User
9. Industry Landscape
9.1 Overview
9.1.1 Overview
10. Company Profiles
10.1 ICU Medical Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Grifols SA
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Pfizer Inc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Baxter International Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 B Braun SE
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Fresenius Kabi AG
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Vifor Pharma Management AG
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Aculife Healthcare Pvt Ltd
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Parenteral Nutrition Market Segmentation
Table 2. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 3. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 4. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 5. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 7. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 8. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 9. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 10. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 11. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 13. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 14. Recent Organic Growth Strategies in the Parenteral Nutrition Market
Table 15. Glossary of Terms, Parenteral Nutrition Market
List of Figures
Figure 1. Parenteral Nutrition Market Segmentation, By Country
Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)
Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)
Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
Figure 16. Asia Pacific: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 17. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 18. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 19. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 20. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 21. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 22. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
1. ICU Medical Inc
2. Grifols SA
3. Pfizer Inc
4. Otsuka Pharmaceuticals Co Ltd
5. Baxter International Inc
6. B Braun SE
7. Fresenius Kabi AG
8. Aculife Healthcare Pvt Ltd
9. Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
10. Vifor Pharma Management AG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific parenteral nutrition market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific parenteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific parenteral nutrition market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.